MedTrace Logo

Use of Eye Movement Tracking to Detect Oculomotor Abnormality in Traumatic Brain Injury Patients

NCT02776462 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 321

Last updated 2018-09-07

No results posted yet for this study

Summary

The purpose of this study is to determine the sensitivity and specificity of an aid in assessment of concussion based on eye-tracking, in comparison to a clinical reference standard appropriate for the Emergency Department (ED) or concussion clinic.

Conditions

  • Brain Concussion
  • Cerebral Concussion
  • Concussion, Intermediate
  • Concussion, Mild
  • Concussion, Severe
  • Trauma, Nervous System
  • Craniocerebral Trauma
  • Brain Injuries

Interventions

DEVICE

EyeBox CNS

Sponsors & Collaborators

  • Oculogica, Inc.

    lead INDUSTRY

Principal Investigators

  • Uzma Samadani, M.D., Ph.D. · Hennepin County Medical Center, Minneapolis

Eligibility

Min Age
5 Years
Max Age
67 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-06-30
Primary Completion
2017-11-16
Completion
2018-06-19
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02776462 on ClinicalTrials.gov